Capital raised by Porosome Therapeutics
1 Form D filing · first filed Sep 2023 · Boston, MA
Chief Executive Officer
Signatory on Porosome Therapeutics's Form D filings · $3.6M raised across 1
Guillermo Marmol is on file as Chief Executive Officer at Porosome Therapeutics in Boston, MA. Porosome Therapeutics has 1 Form D filing on record, $3.6M raised in total. Guillermo Marmol appears as a signatory on the company's filings.
No other people are on file at Porosome Therapeutics. Form D filings only name the signatory and the company's executive officers.
A first-in-class, disease-modifying biologic approach that introduces functional porosomes into the plasma membrane of diseased cells to restore normal secretion, combined in the lead program with a small-molecule flavonoid.
